|
"qin s"的相關文件
顯示項目 1-50 / 73 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-08 |
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study
|
Oh, DY;He, AR;Bouattour, M;Okusaka, T;Qin, S;Chen, LT;Kitano, M;Lee, CK;Kim, JW;Chen, MH;Suksombooncharoen, T;Ikeda, M;Lee, MA;Chen, JS;Potemski, P;Burris, HA, 3rd;Ostwal, V;Tanasanvimon, S;Morizane, C;Zaucha, RE;McNamara, MG;Avallone, A;Cundom, JE;Breder, V;Tan, B;Shimizu, S;Tougeron, D;Evesque, L;Petrova, M;Zhen, DB;Gillmore, R;Gupta, VG;Dayyani, F;Park, JO;Buchschacher, GL, Jr.;Rey, F;Kim, H;Wang, J;Morgan, C;Rokutanda, N;Żotkiewicz, M;Vogel, A;Valle, JW |
| 國家衛生研究院 |
2023-03-31 |
Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC) [Erratum:Annals of Oncology. 2022 Nov;33(Suppl. 9):S1462
|
Oh, D;He, AR;Qin, S;Chen, L;Okusaka, T;Vogel, A;Kim, JW;Suksombooncharoen, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasa, S;Zaucha, RE;Avallone, A;Cundom, JE;Rokutanda, N;Żotkiewicz, M;Cohen, G;Valle, JW |
| 國立成功大學 |
2023 |
Effects of Boundary Conditions on Performance Prediction of Deep-Buried Ground Heat Exchangers for Geothermal Energy Utilization
|
Ma, Z.;Qin, S.;Zhang, Y.;Chen, W.-H.;Jia, G.;Cheng, Cheng C.;Jin, L. |
| 國立成功大學 |
2023 |
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
|
Oh, D.-Y.;He, A.R.;Qin, S.;Chen, L.-T.;Okusaka, T.;Vogel, A.;Kim, J.W.;Suksombooncharoen, T.;Lee, M.A.;Kitano, M.;Burris, H.;Bouattour, M.;Tanasanvimon, S.;McNamara, McNamara M.G.;Zaucha, R.;Avallone, Avallone A.;Tan, B.;Cundom, J.;Lee, C.-K.;Takahashi, H.;Ikeda, M.;Chen, J.-S.;Wang, J.;Makowsky, Makowsky M.;Rokutanda, N.;Żotkiewicz, M.;Kurland, J.F.;Cohen, G.;Valle, J.W. |
| 國家衛生研究院 |
2022-11 |
Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)
|
Oh, DY;He, AR;Qin, S;Chen, LT;Okusaka, T;Vogel, A;Kim, JW;Lee, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasanvimon, S;Zaucha, RE;Avallone, A;Cundom, JE;Rokutanda, N;Zotkiewicz, M;Cohen, G;Valle, JW |
| 臺大學術典藏 |
2022-09-20T06:48:39Z |
Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
|
Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Lam C.S.P.; Hung C.-L.; Liew H.B.; Narasimhan C.; Ngarmukos T.; Park S.W.; Reyes E.; Siswanto B.B.; Shimizu W.; Zhang S.; Fan X.; Chen K.; Wu L.; Xie Y.; Jin Q.; Ling T.; Li X.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Yu C.M.; Sastry B.K.S.; Gopi A.; Raghu K.; Sridevi C.; Kaur D.; Naik A.; Parikh K.; Chandarana A.; Shah U.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Tandon R.; Chopra V.; Kumar M.; Sethi H.J.S.; Verma R.; Mittal S.; Sawhney J.; Sharma M.K.; Purayil M.P.; Tedjokusumo P.; Martanto E.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Danny S.S.; Surarso R.; Noda T.; Nakajima I.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Kabuki T.; Kiuchi S.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Park S.-M.; Roh S.-Y.; Kim Y.H.; Kim M.; Choi J.-I.; Na J.O.; Rha S.W.; Seo H.S.; Oh D.J.; Park C.G.; Kim E.J.; Joung B.; Uhm J.-S.; Lee M.H.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Saharudin S.; Beh B.C.; Lee Y.W.; Yen C.H.; Othman M.K.; Augustine A.-A.; Asnawi M.H.M.; Mojolou R.A.; Tan Y.Z.; Arbain A.N.; Wong C.K.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Azmee M.G.; Abidin I.Z.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Amin N.H.M.; Seng K.C.; Tan S.K.; Yew K.L.; Santos J.; Lim A.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Tan B.Y.; Lim C.P.; Teo L.L.Y.; Chan L.L.H.; Chai P.; Wong C.C.R.; Poh K.K.; Yeo P.S.D.; Lee E.M.; Loh S.Y.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Jaufeerally F.R.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I.; Kuo J.-Y.; Yen C.-H.; HWANG, JUEY-JEN; Chien K.-L.; Su T.-C.; Lin L.-Y.; Juang J.-M.; Lin Y.-H.; Chiang F.-T.; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Hung C.-S.; Chang S.-N.; Lin J.-W.; Hsu C.-N.; Yu W.-C.; Chao T.-F.; Sung S.-H.; Wang K.-L.; Leu H.-B.; Lin Y.-J.; Chang S.-L.; Huang P.-H.; Lo L.-W.; Wu C.-H.; Liang H.-Y.; Chang S.-S.; Hsiao L.-C.; Wang Y.-C.; Lu C.-R.; Wu H.-P.; Lin Y.-N.; Chen K.-W.; Lo P.-H.; Hsu C.-H.; Hsieh L.-C.; Chandavimol M.; Yingchoncharoen T.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators |
| 臺大學術典藏 |
2022-09-06T02:41:54Z |
Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
|
Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Lam C.S.P.; Hung C.-L.; Liew H.B.; Narasimhan C.; Ngarmukos T.; Park S.W.; Reyes E.; Siswanto B.B.; Shimizu W.; Zhang S.; Fan X.; Chen K.; Wu L.; Xie Y.; Jin Q.; Ling T.; Li X.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Yu C.M.; Sastry B.K.S.; Gopi A.; Raghu K.; Sridevi C.; Kaur D.; Naik A.; Parikh K.; Chandarana A.; Shah U.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Tandon R.; Chopra V.; Kumar M.; Sethi H.J.S.; Verma R.; Mittal S.; Sawhney J.; Sharma M.K.; Purayil M.P.; Tedjokusumo P.; Martanto E.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Danny S.S.; Surarso R.; Noda T.; Nakajima I.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Kabuki T.; Kiuchi S.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Park S.-M.; Roh S.-Y.; Kim Y.H.; Kim M.; Choi J.-I.; Na J.O.; Rha S.W.; Seo H.S.; Oh D.J.; Park C.G.; Kim E.J.; Joung B.; Uhm J.-S.; Lee M.H.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Saharudin S.; Beh B.C.; Lee Y.W.; Yen C.H.; Othman M.K.; Augustine A.-A.; Asnawi M.H.M.; Mojolou R.A.; Tan Y.Z.; Arbain A.N.; Wong C.K.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Azmee M.G.; Abidin I.Z.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Amin N.H.M.; Seng K.C.; Tan S.K.; Yew K.L.; Santos J.; Lim A.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Tan B.Y.; Lim C.P.; Teo L.L.Y.; Chan L.L.H.; Chai P.; Wong C.C.R.; Poh K.K.; Yeo P.S.D.; Lee E.M.; Loh S.Y.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Jaufeerally F.R.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I.; Kuo J.-Y.; Yen C.-H.; Hwang J.-J.; Chien K.-L.; Su T.-C.; LIAN-YU LIN; Juang J.-M.; Lin Y.-H.; Chiang F.-T.; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Hung C.-S.; Chang S.-N.; Lin J.-W.; Hsu C.-N.; Yu W.-C.; Chao T.-F.; Sung S.-H.; Wang K.-L.; Leu H.-B.; Lin Y.-J.; Chang S.-L.; Huang P.-H.; Lo L.-W.; Wu C.-H.; Liang H.-Y.; Chang S.-S.; Hsiao L.-C.; Wang Y.-C.; Lu C.-R.; Wu H.-P.; Lin Y.-N.; Chen K.-W.; Lo P.-H.; Hsu C.-H.; Hsieh L.-C.; Chandavimol M.; Yingchoncharoen T.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators |
| 國家衛生研究院 |
2022-09 |
Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)
|
Oh, DY;He, AR;Qin, S;Chen, LT;Okusaka, T;Vogel, A;Kim, JW;Suksombooncharoen, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasanvimon, S;Zaucha, RE;Avallone, A;Cundom, JE;Rokutanda, N;Watras, M;Cohen, G;Valle, JW |
| 臺大學術典藏 |
2022-08-19T06:48:44Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; Hsu C.-H.; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N.; Chao Y.; Chen J.-S.; Bang Y.-J.; Bendell J.; Lee K.-H.; Wang Y.; Abdullah H.; Liu B.; Spahn J.; Hack S.P.; Verret W.; CHIH-HUNG HSU; Lee M.S. |
| 臺大學術典藏 |
2022-08-19T00:21:03Z |
Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion
|
Chen P.-J.; Furuse J.; Han K.-H.; CHIUN HSU; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W. |
| 臺大學術典藏 |
2022-08-19T00:20:34Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Douillard J.-Y.; Yoshino T.; Yen Y.; Hsu C.-H.; Tabernero J.; Shen Y.-C.; CHIUN HSU; Chen S.-C.; Huang Y.-H.; Yen C.-J.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Pentheroudakis G.; Cheng A.-L.; Chen L.-T.; Martinelli E. |
| 臺大學術典藏 |
2022-08-19T00:20:33Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Tebbutt N.; Strickler J.; Stein S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Gane E.; George B.; He A.R.; Hochster H.; CHIUN HSU; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Dev A.; Davis S.L.; Chung H.C.; Chen J.-S.; Chao Y.; Bendell J.; Bang Y.-J.; Lee K.-H.; He A.R.; Wang Y.; Liu B.; Abdullah H.; Hack S.P.; Spahn J.; Lee M.S.; Ryoo B.-Y.; Hsu C.-H.; Numata K.; Stein S.; Verret W. |
| 國家衛生研究院 |
2022-07-04 |
Improving polygenic prediction in ancestrally diverse populations [Erratum:Nature Genetics. 2022 May 5;54(5):573-580.]
|
Ruan, Y;Lin, YF;Feng, YA;Chen, CY;Lam, M;Guo, Z;He, L;Sawa, A;Martin, AR;Qin, S;Huang, H;Ge, T |
| 臺大學術典藏 |
2022-06-10T06:10:59Z |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin S.; Chan S.L.; Sukeepaisarnjaroen W.; Han G.; Choo S.P.; Sriuranpong V.; Pan H.; Yau T.; Guo Y.; Chen M.; Ren Z.; Xu J.; Yen C.-J.; ZHONG-ZHE LIN; Manenti L.; Gu Y.; Sun Y.; Tiedt R.; Hao L.; Song W.; Tanwandee T. |
| 臺大學術典藏 |
2022-05-05T05:15:33Z |
Comparative genetic architectures of schizophrenia in East Asian and European populations
|
Lam M.; Chen C.-Y.; Li Z.; Martin A.R.; Bryois J.; Ma X.; Gaspar H.; Ikeda M.; Benyamin B.; Brown B.C.; Liu R.; Zhou W.; Guan L.; Kamatani Y.; Kim S.-W.; Kubo M.; Kusumawardhani A.A.A.A.; Liu C.-M.; Ma H.; Periyasamy S.; Takahashi A.; Xu Z.; Yu H.; Zhu F.; WEI J. CHEN; Faraone S.; Glatt S.J.; He L.; Hyman S.E.; Hwu H.-G.; McCarroll S.A.; Neale B.M.; Sklar P.; Wildenauer D.B.; Yu X.; Zhang D.; Mowry B.J.; Lee J.; Holmans P.; Xu S.; Sullivan P.F.; Ripke S.; O��Donovan M.C.; Daly M.J.; Qin S.; Sham P.; Iwata N.; Hong K.S.; Schwab S.G.; Yue W.; Tsuang M.; Liu J.; Ma X.; Kahn R.S.; Shi Y.; Huang H.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium, Genetic REsearch on schizophreniA neTwork-China; the Netherlands (GREAT-CN); WEI J. CHEN |
| 國家衛生研究院 |
2022-05-05 |
Improving polygenic prediction in ancestrally diverse populations
|
Ruan, Y;Lin, YF;Feng, YA;Chen, CY;Lam, M;Guo, Z;He, L;Sawa, A;Martin, AR;Qin, S;Huang, H;Ge, T |
| 臺大學術典藏 |
2022-04-28T12:31:26Z |
Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
|
Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Lam C.S.P.; Hung C.-L.; Liew H.B.; Narasimhan C.; Ngarmukos T.; Park S.W.; Reyes E.; Siswanto B.B.; Shimizu W.; Zhang S.; Fan X.; Chen K.; Wu L.; Xie Y.; Jin Q.; Ling T.; Li X.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Yu C.M.; Sastry B.K.S.; Gopi A.; Raghu K.; Sridevi C.; Kaur D.; Naik A.; Parikh K.; Chandarana A.; Shah U.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Tandon R.; Chopra V.; Kumar M.; Sethi H.J.S.; Verma R.; Mittal S.; Sawhney J.; Sharma M.K.; Purayil M.P.; Tedjokusumo P.; Martanto E.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Danny S.S.; Surarso R.; Noda T.; Nakajima I.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Kabuki T.; Kiuchi S.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Park S.-M.; Roh S.-Y.; Kim Y.H.; Kim M.; Choi J.-I.; Na J.O.; Rha S.W.; Seo H.S.; Oh D.J.; Park C.G.; Kim E.J.; Joung B.; Uhm J.-S.; Lee M.H.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Saharudin S.; Beh B.C.; Lee Y.W.; Yen C.H.; Othman M.K.; Augustine A.-A.; Asnawi M.H.M.; Mojolou R.A.; Tan Y.Z.; Arbain A.N.; Wong C.K.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Azmee M.G.; Abidin I.Z.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Amin N.H.M.; Seng K.C.; Tan S.K.; Yew K.L.; Santos J.; Lim A.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Tan B.Y.; Lim C.P.; Teo L.L.Y.; Chan L.L.H.; Chai P.; Wong C.C.R.; Poh K.K.; Yeo P.S.D.; Lee E.M.; Loh S.Y.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Jaufeerally F.R.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I.; Kuo J.-Y.; Yen C.-H.; Hwang J.-J.; Chien K.-L.; Su T.-C.; Lin L.-Y.; Juang J.-M.; Lin Y.-H.; Chiang F.-T.; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Hung C.-S.; Chang S.-N.; Lin J.-W.; Hsu C.-N.; Yu W.-C.; Chao T.-F.; Sung S.-H.; Wang K.-L.; Leu H.-B.; Lin Y.-J.; Chang S.-L.; Huang P.-H.; Lo L.-W.; Wu C.-H.; Liang H.-Y.; Chang S.-S.; Hsiao L.-C.; Wang Y.-C.; Lu C.-R.; Wu H.-P.; Lin Y.-N.; Chen K.-W.; Lo P.-H.; Hsu C.-H.; Hsieh L.-C.; Chandavimol M.; Yingchoncharoen T.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators; KUO-LIONG CHIEN |
| 國家衛生研究院 |
2022-04-08 |
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
|
Trubetskoy, V;Pardiñas, AF;Qi, T;Panagiotaropoulou, G;Awasthi, S;Bigdeli, TB;Bryois, J;Chen, CY;Dennison, CA;Hall, LS;Lam, M;Watanabe, K;Frei, O;Ge, T;Harwood, JC;Koopmans, F;Magnusson, S;Richards, AL;Sidorenko, J;Wu, Y;Zeng, J;Grove, J;Kim, M;Li, Z;Voloudakis, G;Zhang, W;Adams, M;Agartz, I;Atkinson, EG;Agerbo, E;Al Eissa, M;Albus, M;Alexander, M;Alizadeh, BZ;Alptekin, K;Als, TD;Amin, F;Arolt, V;Arrojo, M;Athanasiu, L;Azevedo, MH;Bacanu, SA;Bass, NJ;Begemann, M;Belliveau, RA;Bene, J;Benyamin, B;Bergen, SE;Blasi, G;Bobes, J;Bonassi, S;Braun, A;Bressan, RA;Bromet, EJ;Bruggeman, R;Buckley, PF;Buckner, RL;Bybjerg-Grauholm, J;Cahn, W;Cairns, MJ;Calkins, ME;Carr, VJ;Castle, D;Catts, SV;Chambert, KD;Chan, RCK;Chaumette, B;Cheng, W;Cheung, EFC;Chong, SA;Cohen, D;Consoli, A;Cordeiro, Q;Costas, J;Curtis, C;Davidson, M;Davis, KL;de Haan, L;Degenhardt, F;DeLisi, LE;Demontis, D;Dickerson, F;Dikeos, D;Dinan, T;Djurovic, S;Duan, J;Ducci, G;Dudbridge, F;Eriksson, JG;Fañanás, L;Faraone, SV;Fiorentino, A;Forstner, A;Frank, J;Freimer, NB;Fromer, M;Frustaci, A;Gadelha, A;Genovese, G;Gershon, ES;Giannitelli, M;Giegling, I;Giusti-Rodríguez, P;Godard, S;Goldstein, JI;González Peñas, J;González-Pinto, A;Gopal, S;Gratten, J;Green, MF;Greenwood, TA;Guillin, O;Gülöksüz, S;Gur, RE;Gur, RC;Gutiérrez, B;Hahn, E;Hakonarson, H;Haroutunian, V;Hartmann, AM;Harvey, C;Hayward, C;Henskens, FA;Herms, S;Hoffmann, P;Howrigan, DP;Ikeda, M;Iyegbe, C;Joa, I;Julià, A;Kähler, AK;Kam-Thong, T;Kamatani, Y;Karachanak-Yankova, S;Kebir, O;Keller, MC;Kelly, BJ;Khrunin, A;Kim, SW;Klovins, J;Kondratiev, N;Konte, B;Kraft, J;Kubo, M;Kučinskas, V;Kučinskiene, ZA;Kusumawardhani, A;Kuzelova-Ptackova, H;Landi, S;Lazzeroni, LC;Lee, PH;Legge, SE;Lehrer, DS;Lencer, R;Lerer, B;Li, M;Lieberman, J;Light, GA;Limborska, S;Liu, CM;Lönnqvist, J;Loughland, CM;Lubinski, J;Luykx, JJ;Lynham, A;Macek, M, Jr.;Mackinnon, A;Magnusson, PKE;Maher, BS;Maier, W;Malaspina, D;Mallet, J;Marder, SR;Marsal, S;Martin, AR;Martorell, L;Mattheisen, M;McCarley, RW;McDonald, C;McGrath, JJ;Medeiros, H;Meier, S;Melegh, B;Melle, I;Mesholam-Gately, RI;Metspalu, A;Michie, PT;Milani, L;Milanova, V;Mitjans, M;Molden, E;Molina, E;Molto, MD;Mondelli, V;Moreno, C;Morley, CP;Muntané, G;Murphy, KC;Myin-Germeys, I;Nenadić, I;Nestadt, G;Nikitina-Zake, L;Noto, C;Nuechterlein, KH;O'Brien, NL;O'Neill, FA;Oh, SY;Olincy, A;Ota, VK;Pantelis, C;Papadimitriou, GN;Parellada, M;Paunio, T;Pellegrino, R;Periyasamy, S;Perkins, DO;Pfuhlmann, B;Pietiläinen, O;Pimm, J;Porteous, D;Powell, J;Quattrone, D;Quested, D;Radant, AD;Rampino, A;Rapaport, MH;Rautanen, A;Reichenberg, A;Roe, C;Roffman, JL;Roth, J;Rothermundt, M;Rutten, BPF;Saker-Delye, S;Salomaa, V;Sanjuan, J;Santoro, ML;Savitz, A;Schall, U;Scott, RJ;Seidman, LJ;Sharp, SI;Shi, J;Siever, LJ;Sigurdsson, E;Sim, K;Skarabis, N;Slominsky, P;So, HC;Sobell, JL;Söderman, E;Stain, HJ;Steen, NE;Steixner-Kumar, AA;Stögmann, E;Stone, WS;Straub, RE;Streit, F;Strengman, E;Stroup, TS;Subramaniam, M;Sugar, CA;Suvisaari, J;Svrakic, DM;Swerdlow, NR;Szatkiewicz, JP;Ta, TMT;Takahashi, A;Terao, C;Thibaut, F;Toncheva, D;Tooney, PA;Torretta, S;Tosato, S;Tura, GB;Turetsky, BI;Üçok, A;Vaaler, A;van Amelsvoort, T;van Winkel, R;Veijola, J;Waddington, J;Walter, H;Waterreus, A;Webb, BT;Weiser, M;Williams, NM;Witt, SH;Wormley, BK;Wu, JQ;Xu, Z;Yolken, R;Zai, CC;Zhou, W;Zhu, F;Zimprich, F;Atbaşoğlu, EC;Ayub, M;Benner, C;Bertolino, A;Black, DW;Bray, NJ;Breen, G;Buccola, NG;Byerley, WF;Chen, WJ;Cloninger, CR;Crespo-Facorro, B;Donohoe, G;Freedman, R;Galletly, C;Gandal, MJ;Gennarelli, M;Hougaard, DM;Hwu, HG;Jablensky, AV;McCarroll, SA;Moran, JL;Mors, O;Mortensen, PB;Müller-Myhsok, B;Neil, AL;Nordentoft, M;Pato, MT;Petryshen, TL;Pirinen, M;Pulver, AE;Schulze, TG;Silverman, JM;Smoller, JW;Stahl, EA;Tsuang, DW;Vilella, E;Wang, SH;Xu, S;Adolfsson, R;Arango, C;Baune, BT;Belangero, SI;Børglum, AD;Braff, D;Bramon, E;Buxbaum, JD;Campion, D;Cervilla, JA;Cichon, S;Collier, DA;Corvin, A;Curtis, D;Forti, MD;Domenici, E;Ehrenreich, H;Escott-Price, V;Esko, T;Fanous, AH;Gareeva, A;Gawlik, M;Gejman, PV;Gill, M;Glatt, SJ;Golimbet, V;Hong, KS;Hultman, CM;Hyman, SE;Iwata, N;Jönsson, EG;Kahn, RS;Kennedy, JL;Khusnutdinova, E;Kirov, G;Knowles, JA;Krebs, MO;Laurent-Levinson, C;Lee, J;Lencz, T;Levinson, DF;Li, QS;Liu, J;Malhotra, AK;Malhotra, D;McIntosh, A;McQuillin, A;Menezes, PR;Morgan, VA;Morris, DW;Mowry, BJ;Murray, RM;Nimgaonkar, V;Nöthen, MM;Ophoff, RA;Paciga, SA;Palotie, A;Pato, CN;Qin, S;Rietschel, M;Riley, BP;Rivera, M;Rujescu, D;Saka, MC;Sanders, AR;Schwab, SG;Serretti, A;Sham, PC;Shi, Y;St Clair, D;Stefánsson, H;Stefansson, K;Tsuang, MT;van Os, J;Vawter, MP;Weinberger, DR;Werge, T;Wildenauer, DB;Yu, X;Yue, W;Holmans, PA;Pocklington, AJ;Roussos, P;Vassos, E;Verhage, M;Visscher, PM;Yang, J;Posthuma, D;Andreassen, OA;Kendler, KS;Owen, MJ;Wray, NR;Daly, MJ;Huang, H;Neale, BM;Sullivan, PF;Ripke, S;Walters, JTR;O'Donovan, MC |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
|
Qin S.; Ren Z.; Feng Y.-H.; Yau T.; Wang B.; Zhao H.; Bai Y.; Gu S.; Li L.; Hernandez S.; Xu D.-Z.; Mulla S.; Wang Y.; Shao H.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT
|
Okusaka T.; Ikeda K.; Kudo M.; Finn R.; Qin S.; Han K.-H.; ANN-LII CHENG; Piscaglia F.; Kobayashi M.; Sung M.; Chen M.; Wyrwicz L.; Yoon J.-H.; Ren Z.; Mody K.; Dutcus C.; Tamai T.; Ren M.; Hayato S.; Kumada H. |
| 臺大學術典藏 |
2022-02-21T02:04:34Z |
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
|
Galle P.R.; Finn R.S.; Qin S.; Ikeda M.; Zhu A.X.; Kim T.-Y.; Kudo M.; Breder V.; Merle P.; Kaseb A.; Li D.; Mulla S.; Verret W.; Xu D.-Z.; Hernandez S.; Ding B.; Liu J.; Huang C.; Lim H.Y.; ANN-LII CHENG; Ducreux M. |
| 臺大學術典藏 |
2022-02-21T02:04:32Z |
Pharmacodynamic biomarkers predictive of survival benefit with lenvatinib in unresectable hepatocellular carcinoma: From the phase III REFLECT study
|
Finn R.S.; Kudo M.; ANN-LII CHENG; Wyrwicz L.; Ngan R.K.C.; Blanc J.-F.; Baron A.D.; Vogel A.; Ikeda M.; Piscaglia F.; Han K.-H.; Qin S.; Minoshima Y.; Kanekiyo M.; Ren M.; Dairiki R.; Tamai T.; Dutcus C.E.; Ikezawa H.; Funahashi Y.; Evans T.R.J. |
| 國家衛生研究院 |
2022-02-01 |
A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1
|
Oh, DY;He, AR;Qin, S;Chen, LT;Okusaka, T;Vogel, A;Kim, JW;Suksombooncharoen, T;Lee, MA;Kitano, M;Burris, HA;Bouattour, M;Tanasanvimon, S;Zaucha, R;Avallone, A;Cundom, J;Rokutanda, N;Xiong, J;Cohen, G;Valle, JW |
| 國立成功大學 |
2022 |
Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study: RAM/PL + BSC for advanced HCC
|
Shao, G.;Bai, Y.;Yuan, X.;Chen, X.;Gu, S.;Gu, K.;Hu, C.;Liang, H.;Guo, Y.;Wang, J.;Yen, C.-J.;Lee, V.H.-F.;Wang, C.;Widau, R.C.;Zhang, W.;Liu, J.;Zhang, Q.;Qin, S. |
| 國立成功大學 |
2022 |
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
|
Chan, S.L.;Schuler, M.;Kang, Y.-K.;Yen, C.-J.;Edeline, J.;Choo, S.P.;Lin, C.-C.;Okusaka, T.;Weiss, K.-H.;Macarulla, T.;Cattan, S.;Blanc, J.-F.;Lee, K.-H.;Maur, Maur M.;Pant, S.;Kudo, M.;Assenat, E.;Zhu, A.X.;Yau, T.;Lim, H.Y.;Bruix, J.;Geier, A.;Guill�n-Ponce, C.;Fasolo, A.;Finn, R.S.;Fan, J.;Vogel, A.;Qin, S.;Riester, M.;Katsanou, V.;Chaudhari, M.;Kakizume, T.;Gu, Y.;Porta, D.G.;Myers, A.;Delord, J.-P. |
| 國立成功大學 |
2022 |
Improving polygenic prediction in ancestrally diverse populations
|
Ruan, Y.;Lin, Y.-F.;Feng, Y.-C.A.;Chen, Chen C.-Y.;Lam, M.;Guo, Z.;Ahn, Y.M.;Akiyama, K.;Arai, M.;Baek, J.H.;Chen, W.J.;Chung, Y.-C.;Feng, G.;Fujii, K.;Glatt, S.J.;Ha, K.;Hattori, K.;Higuchi, T.;Hishimoto, A.;Hong, K.S.;Horiuchi, Y.;Hwu, Hwu H.-G.;Ikeda, M.;Ishiwata, S.;Itokawa, M.;Iwata, N.;Joo, E.-J.;Kahn, R.S.;Kim, S.-W.;Kim, S.J.;Kim, S.H.;Kinoshita, M.;Kunugi, H.;Kusumawardhani, A.;Lee, J.;Lee, B.D.;Lee, H.-J.;Liu, J.;Liu, R.;Ma, X.;Myung, W.;Numata, S.;Ohmori, T.;Otsuka, I.;Ozeki, Y.;Schwab, Schwab S.G.;Shi, W.;Shimoda, K.;Sim, K.;Sora, I.;Tang, J.;Toyota, Toyota T.;Tsuang, M.;Wildenauer, D.B.;Won, H.-H.;Yoshikawa, T.;Zheng, A.;Zhu, F.;He, L.;Sawa, A.;Martin, A.R.;Qin, S.;Huang, Huang H.;Ge, T.;Initiatives, Stanley Global Asia |
| 臺大學術典藏 |
2021-10-22T07:39:40Z |
Comparative genetic architectures of schizophrenia in East Asian and European populations
|
Lam M.; Chen C.-Y.; Li Z.; Martin A.R.; Bryois J.; Ma X.; Gaspar H.; Ikeda M.; Benyamin B.; Brown B.C.; Liu R.; Zhou W.; Guan L.; Kamatani Y.; Kim S.-W.; Kubo M.; Kusumawardhani A.A.A.A.; Liu C.-M.; Ma H.; Periyasamy S.; Takahashi A.; Xu Z.; Yu H.; Zhu F.; Chen W.J.; Faraone S.; Glatt S.J.; He L.; Hyman S.E.; HAI-GWO HWU; McCarroll S.A.; Neale B.M.; Sklar P.; Wildenauer D.B.; Yu X.; Zhang D.; Mowry B.J.; Lee J.; Holmans P.; Xu S.; Sullivan P.F.; Ripke S.; O’Donovan M.C.; Daly M.J.; Qin S.; Sham P.; Iwata N.; Hong K.S.; Schwab S.G.; Yue W.; Tsuang M.; Liu J.; Ma X.; Kahn R.S.; Shi Y.; Huang H.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium, Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN) |
| 臺大學術典藏 |
2021-09-23T08:02:06Z |
Comparative genetic architectures of schizophrenia in East Asian and European populations
|
Lam M.; Chen C.-Y.; Li Z.; Martin A.R.; Bryois J.; Ma X.; Gaspar H.; Ikeda M.; Benyamin B.; Brown B.C.; Liu R.; Zhou W.; Guan L.; Kamatani Y.; Kim S.-W.; Kubo M.; Kusumawardhani A.A.A.A.; CHIH-MIN LIU; Ma H.; Periyasamy S.; Takahashi A.; Xu Z.; Yu H.; Zhu F.; Chen W.J.; Faraone S.; Glatt S.J.; He L.; Hyman S.E.; Hwu H.-G.; McCarroll S.A.; Neale B.M.; Sklar P.; Wildenauer D.B.; Yu X.; Zhang D.; Mowry B.J.; Lee J.; Holmans P.; Xu S.; Sullivan P.F.; Ripke S.; O’Donovan M.C.; Daly M.J.; Qin S.; Sham P.; Iwata N.; Hong K.S.; Schwab S.G.; Yue W.; Tsuang M.; Liu J.; Ma X.; Kahn R.S.; Shi Y.; Huang H.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium, Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN) |
| 臺大學術典藏 |
2021-09-01T01:54:24Z |
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
|
ANN-LII CHENG; Kang Y.-K.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Luo R.; Feng J.; Ye S.; Yang T.-S.; Xu J.; Sun Y.; Liang H.; Liu J.; Wang J.; Tak W.Y.; Pan H.; Burock K.; Zou J.; Voliotis D.; Guan Z. |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
|
ANN-LII CHENG; Guan Z.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Yang T.-S.; Tak W.Y.; Pan H.; Yu S.; Xu J.; Fang F.; Zou J.; Lentini G.; Voliotis D.; Kang Y.-K. |
| 臺大學術典藏 |
2021-09-01T01:53:44Z |
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study
|
Johnson P.J.; Qin S.; Park J.-W.; Poon R.T.P.; Raoul J.-L.; Philip P.A.; Hsu C.-H.; Hu T.-H.; Heo J.; Xu J.; Lu L.; Chao Y.; Boucher E.; Han K.-H.; Paik S.-W.; Robles-Avi?a J.; Kudo M.; Yan L.; Sobhonslidsuk A.; Komov D.; Decaens T.; Tak W.-Y.; Jeng L.-B.; Liu D.; Ezzeddine R.; Walters I.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:43Z |
Sunitinib versus sorafenib in advanced hepatocellular cancer: Results of a randomized phase III trial
|
ANN-LII CHENG; Kang Y.-K.; Lin D.-Y.; Park J.-W.; Kudo M.; Qin S.; Chung H.-C.; Song X.; Xu J.; Poggi G.; Omata M.; Lowenthal S.P.; Lanzalone S.; Yang L.; Lechuga M.J.; Raymond E. |
| 臺大學術典藏 |
2021-08-31T06:29:40Z |
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Bruix J.; Qin S.; Merle P.; Granito A.; Huang Y.-H.; Bodoky G.; Pracht M.; Yokosuka O.; Rosmorduc O.; Breder V.; Gerolami R.; Masi G.; Ross P.J.; Song T.; Bronowicki J.-P.; Ollivier-Hourmand I.; Kudo M.; ANN-LII CHENG; Llovet J.M.; Finn R.S.; LeBerre M.-A.; Baumhauer A.; Meinhardt G.; Han G. |
| 臺大學術典藏 |
2021-08-31T06:29:31Z |
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
|
Bouattour M.; Raymond E.; Qin S.; ANN-LII CHENG; Stammberger U.; Locatelli G.; Faivre S. |
| 臺大學術典藏 |
2021-08-31T06:29:30Z |
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
|
Kudo M.; Finn R.S.; Qin S.; Han K.-H.; Ikeda K.; Piscaglia F.; Baron A.; Park J.-W.; Han G.; Jassem J.; Blanc J.F.; Vogel A.; Komov D.; Evans T.R.J.; Lopez C.; Dutcus C.; Guo M.; Saito K.; Kraljevic S.; Tamai T.; Ren M.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma
|
Alsina A.; Kudo M.; Vogel A.; ANN-LII CHENG; Tak W.Y.; Ryoo B.-Y.; Evans T.R.J.; L?pez L?pez C.; Daniele B.; Misir S.; Ren M.; Izumi N.; Qin S.; Finn R.S. |
| 臺大學術典藏 |
2021-08-31T06:29:18Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen L.-T.; Martinelli E.; ANN-LII CHENG; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Hsu C.; Shen Y.-C.; Tabernero J.; Yen Y.; Hsu C.-H.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-08-31T06:29:17Z |
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
|
Finn R.S.; Qin S.; Ikeda M.; Galle P.R.; Ducreux M.; Kim T.-Y.; Kudo M.; Breder V.; Merle P.; Kaseb A.O.; Li D.; Verret W.; Xu D.-Z.; Hernandez S.; Liu J.; Huang C.; Mulla S.; Wang Y.; Lim H.Y.; Zhu A.X.; ANN-LII CHENG; IMbrave150 Investigators |
| 臺大學術典藏 |
2021-08-31T06:29:17Z |
IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation
|
Hack S.P.; Spahn J.; Chen M.; ANN-LII CHENG; Kaseb A.; Kudo M.; Lee H.C.; Yopp A.; Chow P.; Qin S. |
| 臺大學術典藏 |
2021-08-31T06:29:13Z |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression
|
Ryoo B.-Y.; ANN-LII CHENG; Ren Z.; Kim T.-Y.; Pan H.; Rau K.-M.; Choi H.J.; Park J.-W.; Kim J.H.; Yen C.J.; Lim H.Y.; Zhou D.; Straub J.; Scheele J.; Berghoff K.; Qin S. |
| 臺大學術典藏 |
2021-08-11T03:46:38Z |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin S.; Chan S.L.; Sukeepaisarnjaroen W.; Han G.; Choo S.P.; Sriuranpong V.; Pan H.; Yau T.; Guo Y.; Chen M.; Ren Z.; Xu J.; Yen C.-J.; ZHONG-ZHE LIN; Manenti L.; Gu Y.; Sun Y.; Tiedt R.; Hao L.; Song W.; Tanwandee T. |
| 臺大學術典藏 |
2021-07-03T03:34:45Z |
Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion
|
PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W. |
| 臺大學術典藏 |
2021-07-03T03:34:40Z |
Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma
|
Yeo W.; PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:57Z |
Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial
|
Cainap C.; Qin S.; Huang W.-T.; Chung I.J.; Pan H.; Cheng Y.; Kudo M.; Kang Y.-K.; PEI-JER CHEN; Toh H.-C.; Gorbunova V.; Eskens F.A.L.M.; Qian J.; McKee M.D.; Ricker J.L.; Carlson D.M.; El-Nowiem S. |
| 臺大學術典藏 |
2021-04-20T08:30:33Z |
Comparative genetic architectures of schizophrenia in East Asian and European populations
|
Lam M.;Chen C.-Y.;Li Z.;Martin A.R.;Bryois J.;Ma X.;Gaspar H.;Ikeda M.;Benyamin B.;Brown B.C.;Liu R.;Zhou W.;Guan L.;Kamatani Y.;Kim S.-W.;Kubo M.;Kusumawardhani A.A.A.A.;Liu C.-M.;Ma H.;Periyasamy S.;Takahashi A.;Xu Z.;Yu H.;Zhu F.;Wei J. Chen;Faraone S.;Glatt S.J.;He L.;Hyman S.E.;Hwu H.-G.;Mccarroll S.A.;Neale B.M.;Sklar P.;Wildenauer D.B.;Yu X.;Zhang D.;Mowry B.J.;Lee J.;Holmans P.;Xu S.;Sullivan P.F.;Ripke S.;O’Donovan M.C.;Daly M.J.;Qin S.;Sham P.;Iwata N.;Hong K.S.;Schwab S.G.;Yue W.;Tsuang M.;Liu J.;Ma X.;Kahn R.S.;Shi Y.;Huang H.;Schizophrenia Working Group Of The Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium, Genetic Research On Schizophrenia Network-China;The Netherlands (Great-Cn); Lam M.; Chen C.-Y.; Li Z.; Martin A.R.; Bryois J.; Ma X.; Gaspar H.; Ikeda M.; Benyamin B.; Brown B.C.; Liu R.; Zhou W.; Guan L.; Kamatani Y.; Kim S.-W.; Kubo M.; Kusumawardhani A.A.A.A.; Liu C.-M.; Ma H.; Periyasamy S.; Takahashi A.; Xu Z.; Yu H.; Zhu F.; WEI J. CHEN; Faraone S.; Glatt S.J.; He L.; Hyman S.E.; Hwu H.-G.; McCarroll S.A.; Neale B.M.; Sklar P.; Wildenauer D.B.; Yu X.; Zhang D.; Mowry B.J.; Lee J.; Holmans P.; Xu S.; Sullivan P.F.; Ripke S.; O’Donovan M.C.; Daly M.J.; Qin S.; Sham P.; Iwata N.; Hong K.S.; Schwab S.G.; Yue W.; Tsuang M.; Liu J.; Ma X.; Kahn R.S.; Shi Y.; Huang H.; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Indonesia Schizophrenia Consortium, Genetic REsearch on schizophreniA neTwork-China; the Netherlands (GREAT-CN) |
| 臺大學術典藏 |
2021-03-11T04:29:16Z |
Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
|
Chia Y.M.F.;Teng T.-H.K.;Tay W.T.;Anand I.;Macdonald M.R.;Yap J.;Chandramouli C.;Richards A.M.;Tromp J.;Ouwerkerk W.;Ling L.H.;Lam C.S.P.;Hung C.-L.;Liew H.B.;Narasimhan C.;Ngarmukos T.;Park S.W.;Reyes E.;Siswanto B.B.;Shimizu W.;Zhang S.;Fan X.;Chen K.;Wu L.;Xie Y.;Jin Q.;Ling T.;Li X.;Zhou F.;Zhou Y.;Xu D.;Zhang H.;Su Y.;Chen X.;Qin S.;Wang J.;Gong X.;Wu Z.;Yu C.M.;Sastry B.K.S.;Gopi A.;Raghu K.;Sridevi C.;Kaur D.;Naik A.;Parikh K.;Chandarana A.;Shah U.;Chag M.;Baxi H.;Gupta S.;Bhatia J.;Khakhkhar V.;Sankhla V.;Patel T.;Kapoor V.;Wander G.S.;Tandon R.;Chopra V.;Kumar M.;Sethi H.J.S.;Verma R.;Mittal S.;Sawhney J.;Sharma M.K.;Purayil M.P.;Tedjokusumo P.;Martanto E.;Erwinanto, Munawar M.;Pambudi J.A.;Lukito A.;Pardede I.;Thengker A.;Damay V.;Danny S.S.;Surarso R.;Noda T.;Nakajima I.;Wada M.;Ishibashi K.;Kurita T.;Yasuoka R.;Asai K.;Murai K.;Kubota Y.;Izumi Y.;Ikeda T.;Hisatake S.;Kabuki T.;Kiuchi S.;Hagiwara N.;Suzuki A.;Suzuki T.;Hong S.K.;Lee S.;Soo L.D.;Kim D.-H.;Shim J.;Park S.-M.;Roh S.-Y.;Kim Y.H.;Kim M.;Choi J.-I.;Na J.O.;Rha S.W.;Seo H.S.;Oh D.J.;Park C.G.;Kim E.J.;Joung B.;Uhm J.-S.;Lee M.H.;Cho I.-J.;Park H.-N.;Park H.-W.;Cho J.-G.;Yoon N.;Lee K.;Kim K.H.;Kim S.H.;Saharudin S.;Beh B.C.;Lee Y.W.;Yen C.H.;Othman M.K.;Augustine A.-A.;Asnawi M.H.M.;Mojolou R.A.;Tan Y.Z.;Arbain A.N.;Wong C.K.;Omar R.;Ghazi A.M.;Khelae S.K.;Chew D.S.P.;Yap L.B.;Hussin A.;Muhammad Z.;Azmee M.G.;Abidin I.Z.;Zhudi A.S.B.M.;Sari N.A.M.;Sridhar G.S.;Zuhdi A.S.M.;Ismail M.D.;Ong T.K.;Cham Y.L.;Khiew N.Z.;Said A.B.;Fong A.Y.Y.;Amin N.H.M.;Seng K.C.;Tan S.K.;Yew K.L.;Santos J.;Lim A.;Lapitan R.;Andal R.;Lopez E.;Sim K.L.D.;Tan B.Y.;Lim C.P.;Teo L.L.Y.;Chan L.L.H.;Chai P.;Wong C.C.R.;Poh K.K.;Yeo P.S.D.;Lee E.M.;Loh S.Y.;Ching M.E.;Khoo D.Z.L.;Yew M.S.;Huang W.;Leong K.T.G.;See J.H.J.;Lim Y.B.;Tan S.;Yeo C.;Chai S.C.;Jaufeerally F.R.;Tulsidas H.;Aung T.;Ong H.Y.;Ling L.F.;Soon D.K.N.;Yeh H.-I.;Kuo J.-Y.;Yen C.-H.;Hwang J.-J.;Chien K.-L.;Su T.-C.;Lin L.-Y.;Juang J.-M.;Lin Y.-H.;Fu-Tien Chiang;Lin J.-L.;Ho Y.-L.;Lee C.-M.;Lin P.-C.;Hung C.-S.;Chang S.-N.;Lin J.-W.;Hsu C.-N.;Yu W.-C.;Chao T.-F.;Sung S.-H.;Wang K.-L.;Leu H.-B.;Lin Y.-J.;Chang S.-L.;Huang P.-H.;Lo L.-W.;Wu C.-H.;Liang H.-Y.;Chang S.-S.;Hsiao L.-C.;Wang Y.-C.;Lu C.-R.;Wu H.-P.;Lin Y.-N.;Chen K.-W.;Lo P.-H.;Hsu C.-H.;Hsieh L.-C.;Chandavimol M.;Yingchoncharoen T.;Laothavorn P.;Tiyanon W.;Wongcharoen W.;Phrommintikul A.;On Behalf Of The Asian-Hf Investigators; Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Lam C.S.P.; Hung C.-L.; Liew H.B.; Narasimhan C.; Ngarmukos T.; Park S.W.; Reyes E.; Siswanto B.B.; Shimizu W.; Zhang S.; Fan X.; Chen K.; Wu L.; Xie Y.; Jin Q.; Ling T.; Li X.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Yu C.M.; Sastry B.K.S.; Gopi A.; Raghu K.; Sridevi C.; Kaur D.; Naik A.; Parikh K.; Chandarana A.; Shah U.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Tandon R.; Chopra V.; Kumar M.; Sethi H.J.S.; Verma R.; Mittal S.; Sawhney J.; Sharma M.K.; Purayil M.P.; Tedjokusumo P.; Martanto E.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Danny S.S.; Surarso R.; Noda T.; Nakajima I.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Kabuki T.; Kiuchi S.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Park S.-M.; Roh S.-Y.; Kim Y.H.; Kim M.; Choi J.-I.; Na J.O.; Rha S.W.; Seo H.S.; Oh D.J.; Park C.G.; Kim E.J.; Joung B.; Uhm J.-S.; Lee M.H.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Saharudin S.; Beh B.C.; Lee Y.W.; Yen C.H.; Othman M.K.; Augustine A.-A.; Asnawi M.H.M.; Mojolou R.A.; Tan Y.Z.; Arbain A.N.; Wong C.K.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Azmee M.G.; Abidin I.Z.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Amin N.H.M.; Seng K.C.; Tan S.K.; Yew K.L.; Santos J.; Lim A.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Tan B.Y.; Lim C.P.; Teo L.L.Y.; Chan L.L.H.; Chai P.; Wong C.C.R.; Poh K.K.; Yeo P.S.D.; Lee E.M.; Loh S.Y.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Jaufeerally F.R.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I.; Kuo J.-Y.; Yen C.-H.; Hwang J.-J.; Chien K.-L.; Su T.-C.; Lin L.-Y.; Juang J.-M.; Lin Y.-H.; FU-TIEN CHIANG; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Hung C.-S.; Chang S.-N.; Lin J.-W.; Hsu C.-N.; Yu W.-C.; Chao T.-F.; Sung S.-H.; Wang K.-L.; Leu H.-B.; Lin Y.-J.; Chang S.-L.; Huang P.-H.; Lo L.-W.; Wu C.-H.; Liang H.-Y.; Chang S.-S.; Hsiao L.-C.; Wang Y.-C.; Lu C.-R.; Wu H.-P.; Lin Y.-N.; Chen K.-W.; Lo P.-H.; Hsu C.-H.; Hsieh L.-C.; Chandavimol M.; Yingchoncharoen T.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators |
| 臺大學術典藏 |
2021-03-09T05:18:30Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen L.-T.; Martinelli E.; Cheng A.-L.; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Hsu C.; Ying-Chun Shen; Tabernero J.; Yen Y.; Hsu C.-H.; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-02-19T06:52:27Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Lee M.S.;Ryoo B.-Y.;Chih-Hung Hsu;Numata K.;Stein S.;Verret W.;Hack S.P.;Spahn J.;Liu B.;Abdullah H.;Wang Y.;He A.R.;Lee K.-H.;Bang Y.-J.;Bendell J.;Chao Y.;Chen J.-S.;Chung H.C.;Davis S.L.;Dev A.;Gane E.;George B.;He A.R.;Hochster H.;Chih-Hung Hsu;Ikeda M.;Lee J.;Lee M.;Mahipal A.;Manji G.;Morimoto M.;Numata K.;Pishvaian M.;Qin S.;Ryan D.;Ryoo B.-Y.;Sasahira N.;Stein S.;Strickler J.;Tebbutt N.; Lee M.S.; Ryoo B.-Y.; CHIH-HUNG HSU; Numata K.; Stein S.; Verret W.; Hack S.P.; Spahn J.; Liu B.; Abdullah H.; Wang Y.; He A.R.; Lee K.-H.; Bang Y.-J.; Bendell J.; Chao Y.; Chen J.-S.; Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; CHIH-HUNG HSU; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N. |
| 臺大學術典藏 |
2021-02-18T02:33:47Z |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS�VESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen L.-T.;Martinelli E.;Cheng A.-L.;Pentheroudakis G.;Qin S.;Bhattacharyya G.S.;Ikeda M.;Lim H.-Y.;Ho G.F.;Choo S.P.;Ren Z.;Malhotra H.;Ueno M.;Ryoo B.-Y.;Kiang T.C.;Tai D.;Vogel A.;Cervantes A.;Lu S.-N.;Yen C.-J.;Huang Y.-H.;Chen S.-C.;Shen Y.-C.;Tabernero J.;Yen Y.;Chiun Hsu;Yoshino T.;Douillard J.-Y.; Chen L.-T.; Martinelli E.; Cheng A.-L.; Pentheroudakis G.; Qin S.; Bhattacharyya G.S.; Ikeda M.; Lim H.-Y.; Ho G.F.; Choo S.P.; Ren Z.; Malhotra H.; Ueno M.; Ryoo B.-Y.; Kiang T.C.; Tai D.; Vogel A.; Cervantes A.; Lu S.-N.; Yen C.-J.; Huang Y.-H.; Chen S.-C.; Shen Y.-C.; Tabernero J.; Yen Y.; Chiun Hsu; Yoshino T.; Douillard J.-Y. |
| 臺大學術典藏 |
2021-02-18T01:45:22Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Lee M.S.;Ryoo B.-Y.;Numata K.;Stein S.;Verret W.;Hack S.P.;Spahn J.;Liu B.;Abdullah H.;Wang Y.;He A.R.;Lee K.-H.;Bang Y.-J.;Bendell J.;Chao Y.;Chen J.-S.;Chung H.C.;Davis S.L.;Dev A.;Gane E.;George B.;He A.R.;Hochster H.;Chiun Hsu;Ikeda M.;Lee J.;Lee M.;Mahipal A.;Manji G.;Morimoto M.;Numata K.;Pishvaian M.;Qin S.;Ryan D.;Ryoo B.-Y.;Sasahira N.;Stein S.;Strickler J.;Tebbutt N.; Lee M.S.; Ryoo B.-Y.; Numata K.; Stein S.; Verret W.; Hack S.P.; Spahn J.; Liu B.; Abdullah H.; Wang Y.; He A.R.; Lee K.-H.; Bang Y.-J.; Bendell J.; Chao Y.; Chen J.-S.; Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; Chiun Hsu; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N. |
顯示項目 1-50 / 73 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
